ArticleDermatology and therapy2025

Dupilumab versus Lebrikizumab Demonstrates Greater Likelihood of Achieving and Maintaining Improvements in Efficacy Outcomes Using a Placebo-Adjusted Indirect Treatment Comparison.

Sonja Ständer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.